Ivor Royston's Net Worth
Ivor Royston's net worth is estimated to be at least $2,097,325.15 as of 04/25/2024. CoreStreet's estimation of Ivor Royston's net worth is based on their sale of stock and current holding of stock.
Ivor Royston is CEO at Viracta Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 13,379 units of VIRX stock on 08/26/2022. Their biggest sale was on 11/29/2021 when they sold 15,833 units of Viracta Therapeutics Inc stock for $76,315.06. They typically trade 2 times per year.
Total value of insider buys:
- $1,844,480.00
Total value of insider sells:
- $252,845.15
Most recent insider trade:
- Aug. 26, 2022
Ivor Royston's Insider Trading History
| Viracta Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 26, 2022 | CEO | 13,379 | $4.01 | Sell | $53,649.79 |
May 26, 2022 | CEO | 13,162 | $1.90 | Sell | $25,007.80 |
Feb. 28, 2022 | CEO | 14,635 | $2.78 | Sell | $40,685.30 |
Nov. 29, 2021 | CEO | 15,833 | $4.82 | Sell | $76,315.06 |
Nov. 26, 2021 | CEO | 11,914 | $4.80 | Sell | $57,187.20 |
Nov. 15, 2021 | CEO | 8,000 | $5.56 | Buy | $44,480.00 |
| Syndax Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 8, 2016 | Director | 150,000 | $12.00 | Buy | $1,800,000.00 |